|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-9-21
|
|
pubmed:abstractText |
Several studies have attempted to identify predictors of outcome following ischaemic stroke. Reduced stroke severity has been reported with pre admission ASA use, and improved outcomes have been reported with pre admission statin treatment. The interaction between pre treatment medications and clinical response to tPA is less clear. The objective of our study was to assess clinical outcomes in patients with acute ischaemic stroke with respect to pre treatment medications.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1747-4949
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
328-34
|
|
pubmed:meshHeading |
pubmed-meshheading:19765119-Brain Ischemia,
pubmed-meshheading:19765119-Canada,
pubmed-meshheading:19765119-Cohort Studies,
pubmed-meshheading:19765119-Female,
pubmed-meshheading:19765119-Fibrinolytic Agents,
pubmed-meshheading:19765119-Humans,
pubmed-meshheading:19765119-Logistic Models,
pubmed-meshheading:19765119-Male,
pubmed-meshheading:19765119-Patient Admission,
pubmed-meshheading:19765119-Registries,
pubmed-meshheading:19765119-Severity of Illness Index,
pubmed-meshheading:19765119-Stroke,
pubmed-meshheading:19765119-Thrombolytic Therapy,
pubmed-meshheading:19765119-Tissue Plasminogen Activator,
pubmed-meshheading:19765119-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.
|
|
pubmed:affiliation |
Department of Medicine, Division of Neurology, Ottawa Hospital, Ottawa, ON, Canada. dowlatd@yahoo.com
|
|
pubmed:publicationType |
Journal Article
|
